Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
=============
<hr class="w-100" style="border-top: black 1px solid;">

**Abstract:**<br>


**Resources:**<br>
- Protocol is available here at <a href="https://github.com/ohdsi-studies/Covid19VaccineAesiIncidenceCharacterization/raw/master/extras/Vaccine_safety_sensitivity_protocol.pdf" target="_blank">"Sensitivity analysis of design choices for monitoring adverse events of special interest in vaccine safety for BEST"</a>
- Analytic code is available in the Github repository called <a href="https://github.com/ohdsi-studies/Covid19VaccineAesiIncidenceCharacterization" target="_blank">Covid19VaccineAesiIncidenceCharacterization</a>
- Link to publication <a href="https://www.bmj.com/content/373/bmj.n1435" target="_blank">Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study</a>


